← All indications
Gastroparesis
Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.
Drugs by status
Approved for this indication (2)
Phase 4 trials (6)
Phase 3 trials (5)
Phase 2 trials (21)
Phase 1 trials (10)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (37)
- Takeda
- Targacept
- Theravance
- Millennium Pharmaceuticals
- Ironwood Pharmaceuticals
- Forest Laboratories
- Recordati
- AstraZeneca
- Sanofi
- ICOS
- Bird Rock Bio, Inc.
- Chugai
- GlaxoSmithKline
- Motus Therapeutics, Inc.
- Rhythm Pharmaceuticals, Inc.
- Tranzyme, Inc.
- Dartmouth University
- Indiana University
- Johns Hopkins University
- National University of Malaysia
- University of Florida
- University of Iowa
- University of Tehran
- University of Adelaide
- Yale University
- Mayo Clinic
- Kyowa Kirin
- Catholic University of Korea
- University of Wisconsin
- Alfa Wassermann
- +7 more
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (18)
- Palo Alto Medical Foundation
- Children's Hospital of Philadelphia
- Ascension Health
- University of Pennsylvania
- Carle Foundation Hospital
- Carle Physician Group
- Harvard University
- Eastern Regional Medical Center
- Hoosier Cancer Research Network
- Hospital Italiano de Buenos Aires
- Stanford University
- University of Michigan
- University of Rochester
- Columbia University
- Tel Aviv University
- George L. Arnold, MD, FACP
- Carle Health Care Incorporated
- International Glutamate Technical Committee